Download PDF
Pharmacopsychiatry 2019; 52(02): 63-69
DOI: 10.1055/s-0044-101467
Original Paper
© Georg Thieme Verlag KG Stuttgart · New York

DNA Methylation Profiling in a Neuroblastoma Cell Line Exposed to the Antipsychotic Perospirone

Yui Murata
1   Department of Molecular Psychiatry, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, 113-8655, Japan
2   Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, 113-8655, Japan
3   Department of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto City, Kumamoto, 860-8556, Japan
,
Miki Bundo
1   Department of Molecular Psychiatry, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, 113-8655, Japan
3   Department of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto City, Kumamoto, 860-8556, Japan
,
Fumiko Sunaga
1   Department of Molecular Psychiatry, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, 113-8655, Japan
,
Kiyoto Kasai
2   Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, 113-8655, Japan
,
Kazuya Iwamoto
1   Department of Molecular Psychiatry, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, 113-8655, Japan
3   Department of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto City, Kumamoto, 860-8556, Japan
› Author Affiliations
Further Information

Publication History

received 18 September 2017
revised 07 December 2017

accepted 18 January 2018

Publication Date:
27 February 2018 (online)

Also available at
    Permissions and Reprints

Abstract

Introduction Accumulating evidence suggests the importance of epigenetic changes in the brain induced by antipsychotic drugs. However, due to the lack of systematic investigation, their effects on epigenetic status remain largely unclear. During the course of examining the epigenetic effects of antipsychotics, we here focused on perospirone, an atypical antipsychotic drug mainly used in Japan.

Methods Genomic DNA was obtained from human neuroblastoma cells exposed to 2 different doses of perospirone. Comprehensive DNA methylation analysis was performed using the Infinium HumanMethylation450 BeadChip.

Results Of about 470,000 probes, perospirone exposure changed DNA methylation at 4098 probes. These probes were enriched to genes for neural development. Probes showing hypermethylation were mainly found at gene body and intergenic regions, whereas those that showed hypomethylation were located near promoter regions. Additionally, DNA methylation changes were found in the probes for dopamine receptor 2 and serotonin receptor (HTR) 2A and HTR1A, which are the pharmacological targets of atypical antipsychotics.

Discussion Our comprehensive DNA methylation analyses will contribute to a better understanding of detailed pharmacological actions of perospirone.

Key words

epigenetics - antipsychotic drug - HumanMethylation450 BeadChip - SK-N-SH cell
 

  • References

  • 1 Onrust SV, McClellan K. Perospirone. CNS Drugs 2001; 15: 329-337
    CrossrefPubMedGoogle Scholar
  • 2 Takekita Y, Fabbri C, Kato M. et al. Antagonist and partial agonist at the dopamine D2 receptors in drug-naive and non-drug-naive schizophrenia: A randomized, controlled trial. Eur Arch Psychiatry Clin Neurosci 2015; 265: 579-588
    CrossrefPubMedGoogle Scholar
  • 3 Takekita Y, Kato M, Wakeno M. et al. A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients. Prog Neuropsychopharmacol Biol Psychiatry 2013; 40: 110-114
    CrossrefPubMedGoogle Scholar
  • 4 Tsujino N, Nemoto T, Morita K. et al. Long-term efficacy and tolerability of perospirone for young help-seeking people at clinical high risk: A preliminary open trial. Clin Psychopharmacol Neurosci 2013; 11: 132-136
    CrossrefPubMedGoogle Scholar
  • 5 Higuchi Y, Sumiyoshi T, Ito T, Suzuki M. Perospirone normalized P300 and cognitive function in a case of early psychosis. J Clin Psychopharmacol 2013; 33: 263-266
    CrossrefPubMedGoogle Scholar
  • 6 Suzuki H, Gen K, Inoue Y. Comparison of the anti-dopamine D(2) and anti-serotonin 5-HT(2A) activities of chlorpromazine, bromperidol, haloperidol and second-generation antipsychotics parent compounds and metabolites thereof. J Psychopharmacol 2013; 27: 396-400
    CrossrefPubMedGoogle Scholar
  • 7 Iwakawa M, Terao T, Soya A. et al. A novel antipsychotic, perospirone, has antiserotonergic and antidopaminergic effects in human brain: findings from neuroendocrine challenge tests. Psychopharmacology (Berl) 2004; 176: 407-411
    CrossrefPubMedGoogle Scholar
  • 8 Suzuki H, Gen K, Inoue Y. An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 161-168
    CrossrefPubMedGoogle Scholar
  • 9 Okugawa G, Kato M, Wakeno M. et al. Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study. Psychiatry Clin Neurosci 2009; 63: 322-328
    CrossrefPubMedGoogle Scholar
  • 10 Swathy B, Banerjee M. Understanding epigenetics of schizophrenia in the backdrop of its antipsychotic drug therapy. Epigenomics 2017; 9: 721-736
    CrossrefPubMedGoogle Scholar
  • 11 Asai T, Bundo M, Sugawara H. et al. Effect of mood stabilizers on DNA methylation in human neuroblastoma cells. Int J Neuropsychopharmacol 2013; 16: 2285-2294
    CrossrefPubMedGoogle Scholar
  • 12 Murata Y, Nishioka M, Bundo M. et al. Comprehensive DNA methylation analysis of human neuroblastoma cells treated with blonanserin. Neurosci Lett 2014; 563: 123-128
    CrossrefPubMedGoogle Scholar
  • 13 Sugawara H, Bundo M, Asai T. et al. Effects of quetiapine on DNA methylation in neuroblastoma cells. Prog Neuropsychopharmacol Biol Psychiatry 2015; 56: 117-121
    CrossrefPubMedGoogle Scholar
  • 14 Dedeurwaerder S, Defrance M, Calonne E. et al. Evaluation of the Infinium Methylation 450K technology. Epigenomics 2011; 3: 771-784
    CrossrefPubMedGoogle Scholar
  • 15 Chen J, Bardes EE, Aronow BJ, Jegga AG. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res 2009; 37: W305-W311
    CrossrefPubMedGoogle Scholar
  • 16 Hulsen T, de Vlieg J, Alkema W. BioVenn - a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics 2008; 9: 488
    CrossrefPubMedGoogle Scholar
  • 17 Bird AP. CpG-rich islands and the function of DNA methylation. Nature 1986; 321: 209-213
    CrossrefPubMedGoogle Scholar
  • 18 Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 2012; 13: 484-492
    CrossrefPubMedGoogle Scholar
  • 19 Lee YM, Park SH, Shin DI. et al. Oxidative modification of peroxiredoxin is associated with drug-induced apoptotic signaling in experimental models of Parkinson disease. J Biol Chem 2008; 283: 9986-9998
    CrossrefPubMedGoogle Scholar
  • 20 Cumming RC, Dargusch R, Fischer WH, Schubert D. Increase in expression levels and resistance to sulfhydryl oxidation of peroxiredoxin isoforms in amyloid beta-resistant nerve cells. J Biol Chem 2007; 282: 30523-30534
    CrossrefPubMedGoogle Scholar
  • 21 Palmfeldt J, Henningsen K, Eriksen SA. et al. Protein biomarkers of susceptibility and resilience to stress in a rat model of depression. Mol Cell Neurosci 2016; 74: 87-95
    CrossrefPubMedGoogle Scholar
  • 22 Li L, Zhu K, Liu Y. et al. Targeting thioredoxin-1 with siRNA exacerbates oxidative stress injury after cerebral ischemia/reperfusion in rats. Neuroscience 2015; 284: 815-823
    CrossrefPubMedGoogle Scholar
  • 23 Tamasi V, Petschner P, Adori C. et al. Transcriptional evidence for the role of chronic venlafaxine treatment in neurotrophic signaling and neuroplasticity including also Glutamatergic [corrected] - and insulin-mediated neuronal processes. PLoS One 2014; 9: e113662
    CrossrefPubMedGoogle Scholar
  • 24 Buscarlet M, Hermann R, Lo R. et al. Cofactor-activated phosphorylation is required for inhibition of cortical neuron differentiation by Groucho/TLE1. PLoS One 2009; 4: e8107
    CrossrefPubMedGoogle Scholar
  • 25 Buscarlet M, Perin A, Laing A. et al. Inhibition of cortical neuron differentiation by Groucho/TLE1 requires interaction with WRPW, but not Eh1, repressor peptides. J Biol Chem 2008; 283: 24881-24888
    CrossrefPubMedGoogle Scholar
  • 26 Yao J, Liu Y, Husain J. et al. Combinatorial expression patterns of individual TLE proteins during cell determination and differentiation suggest non-redundant functions for mammalian homologs of Drosophila Groucho. Dev Growth Differ 1998; 40: 133-146
    PubMedGoogle Scholar
  • 27 Yao J, Liu Y, Lo R. et al. Disrupted development of the cerebral hemispheres in transgenic mice expressing the mammalian Groucho homologue transducin-like-enhancer of split 1 in postmitotic neurons. Mech Dev 2000; 93: 105-115
    CrossrefPubMedGoogle Scholar
  • 28 Zhang X, Chen HM, Jaramillo E. et al. Histone deacetylase-related protein inhibits AES-mediated neuronal cell death by direct interaction. J Neurosci Res 2008; 86: 2423-2431
    CrossrefPubMedGoogle Scholar
  • 29 Koch M, Veit G, Stricker S. et al. Expression of type XXIII collagen mRNA and protein. J Biol Chem 2006; 281: 21546-21557
    CrossrefPubMedGoogle Scholar
  • 30 Banyard J, Bao L, Hofer MD. et al. Collagen XXIII expression is associated with prostate cancer recurrence and distant metastases. Clin Cancer Res 2007; 13: 2634-2642
    CrossrefPubMedGoogle Scholar
  • 31 Spivey KA, Banyard J, Solis LM. et al. Collagen XXIII: a potential biomarker for the detection of primary and recurrent non-small cell lung cancer. Cancer Epidemiol Biomarkers Prev 2010; 19: 1362-1372
    CrossrefPubMedGoogle Scholar
  • 32 Ebstein F, Lange N, Urban S. et al. Maturation of human dendritic cells is accompanied by functional remodelling of the ubiquitin-proteasome system. Int J Biochem Cell Biol 2009; 41: 1205-1215
    CrossrefPubMedGoogle Scholar
  • 33 Markson G, Kiel C, Hyde R. et al. Analysis of the human E2 ubiquitin conjugating enzyme protein interaction network. Genome Res 2009; 19: 1905-1911
    CrossrefPubMedGoogle Scholar
  • 34 Fagerberg L, Hallstrom BM, Oksvold P. et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics 2014; 13: 397-406
    CrossrefPubMedGoogle Scholar